Adenocarcinoma at the gastroesophageal junction

Ann N Y Acad Sci. 2014 Sep:1325:211-25. doi: 10.1111/nyas.12535.

Abstract

The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the clinical differences between carcinomas arising slightly above, slightly below, and within the gastroesophageal junction (GEJ); information provided by biopsies; information provided by resection specimens following neoadjuvant therapy; histologic differences existing between carcinomas arising slightly above, slightly below, and within the GEJ; differences provided by immunohistochemistry in these tumors; information given by endoscopic mucosal resection specimens; the role of esophageal pyloric gland adenomas as precursors of adenocarcinomas in the region of the cardia; the role of pancreatic metaplasia; Her2 immunoreactivity to make distinctions in the site of origin; and intestinal metaplasia limited to the cardia as a precursor of adenocarcinoma.

Keywords: Her2; OESO; gastroesophageal junction; immunohistochemistry; intestinal metaplasia; neoadjuvant; pyloric gland adenoma.

Publication types

  • Congress

MeSH terms

  • Adenocarcinoma / diagnosis*
  • Adenocarcinoma / therapy
  • Animals
  • Esophageal Neoplasms / diagnosis*
  • Esophageal Neoplasms / therapy
  • Esophagogastric Junction / pathology*
  • Esophagoscopy / methods
  • Humans
  • Paris
  • Stomach Neoplasms / diagnosis*
  • Stomach Neoplasms / therapy

Supplementary concepts

  • Adenocarcinoma Of Esophagus